Previous 10 | Next 10 |
home / stock / konef / konef news
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intel...
VANCOUVER, British Columbia, March 22, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intel...
VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intel...
KetamineOne Capital press release (OTCPK:KONEF): FQ2 Net Loss of C$6.50M Revenue of C$1.66M. For further details see: KetamineOne Capital reports FQ2 results
VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intel...
Wellbeing Digital Sciences (OTCPK:KONEF) announces that Najla Guthrie, the current Chief Research Officer and President of KGK Science, has been appointed as CEO of Wellbeing effective March 31, 2022. Adam Deffett who was appointed Interim CEO in July of 2021, will transition out of the role ...
VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intel...
VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial intel...
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial ...
VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial ...
News, Short Squeeze, Breakout and More Instantly...
KetamineOne Capital Limited Company Name:
KONEF Stock Symbol:
OTCMKTS Market:
KetamineOne Capital Limited Website:
Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...
Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) ( NEO: MEDI ) ( OTC: KONEF ) ( FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psych...
Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...